Mycophenolate mofetil is a prescription drug approved by the Food and Drug Administration (FDA) to prevent rejection in organ transplant recipients. Mycophenolate mofetil is sometimes prescribed off-label to treat eczema. Mycophenolate mofetil is sold under the brand names CellCept and Myfortic.
Mycophenolate mofetil is an immunosuppressant. Mycophenolate mofetil is believed to work by inhibiting the growth of T cells and B cells, which contribute to inflammation in eczema.
How do I take it?
Mycophenolate mofetil is generally prescribed to be taken once daily.
Mycophenolate mofetil comes in tablet form.
The FDA-approved label for Mycophenolate mofetil lists common side effects including headache, drowsiness, fever, cold symptoms, back or muscle pain, depression, anxiety, acne, oral yeast infection, urinary tract infection, asthma or other respiratory problems, blood cell disorders, edema (swelling), stomach upset, abdominal pain, vomiting, diarrhea, constipation, flatulence, changes in heart rate, and weight gain.
Rare but serious side effects listed for Mycophenolate mofetil include severe infections, birth defects, and increased risk for certain types of cancer.
For more details about this treatment, visit:
Mycophenolate mofetil – Drugs.com
Immunosuppressants – National Eczema Association